Success Metrics

Clinical Success Rate
87.0%

Based on 94 completed trials

Completion Rate
87%(94/108)
Active Trials
6(5%)
Results Posted
26%(24 trials)
Terminated
14(11%)

Phase Distribution

Ph phase_4
36
29%
Ph phase_2
15
12%
Ph not_applicable
17
14%
Ph phase_1
16
13%
Ph phase_3
29
23%

Phase Distribution

16

Early Stage

15

Mid Stage

65

Late Stage

Phase Distribution113 total trials
Phase 1Safety & dosage
16(14.2%)
Phase 2Efficacy & side effects
15(13.3%)
Phase 3Large-scale testing
29(25.7%)
Phase 4Post-market surveillance
36(31.9%)
N/ANon-phased studies
17(15.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

84.7%

94 of 111 finished

Non-Completion Rate

15.3%

17 ended early

Currently Active

6

trials recruiting

Total Trials

125

all time

Status Distribution
Active(6)
Completed(94)
Terminated(17)
Other(8)

Detailed Status

Completed94
Terminated14
unknown8
Recruiting4
Withdrawn3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
125
Active
6
Success Rate
87.0%
Most Advanced
Phase 4

Trials by Phase

Phase 116 (14.2%)
Phase 215 (13.3%)
Phase 329 (25.7%)
Phase 436 (31.9%)
N/A17 (15.0%)

Trials by Status

withdrawn32%
recruiting43%
completed9475%
unknown86%
active_not_recruiting22%
terminated1411%

Recent Activity

Clinical Trials (125)

Showing 20 of 125 trialsScroll for more
NCT06231745Phase 3

Paroxetine Safety and Efficacy in Rheumatoid Arthritis

Completed
NCT06049797

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Active Not Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT07070232Phase 1

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Recruiting
NCT04207723Not Applicable

Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation

Recruiting
NCT06799169Phase 4

Management of Acute Tinnitus With Migraine Medications

Active Not Recruiting
NCT06763484Phase 2

Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical Menopause

Completed
NCT04757571Phase 1

The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients

Withdrawn
NCT05725837Phase 2

Effects of Paroxetine on Cardiovascular Function in Septic Patients

Recruiting
NCT06232109Phase 1

Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects

Completed
NCT06065735Phase 1

Concentration-QT Study of Paroxetine in Healthy Adults

Completed
NCT04446039

Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea

Completed
NCT01416220Phase 4

Lithium Versus Paroxetine in Major Depression

Withdrawn
NCT03894085Not Applicable

Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging (fMRI) Study With Paroxetine Treatment

Completed
NCT04218981Not Applicable

Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders

Completed
NCT05175430Phase 1

Effects of SERT Inhibition on the Subjective Response to LSD in Healthy Subjects

Completed
NCT02893371

Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies

Terminated
NCT01049347Phase 3

Amitriptyline and Paroxetine Treatment of Major Depression

Completed
NCT06203275Phase 3

The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus

Unknown
NCT03779789Phase 4

Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment

Completed

Drug Details

Intervention Type
DRUG
Total Trials
125